▶ 調査レポート

世界の炎症性心疾患市場：市場規模・現状・予測
• 英文タイトル：Global Inflammatory Heart Disease Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の炎症性心疾患市場：市場規模・現状・予測 / Global Inflammatory Heart Disease Market Size, Status and Forecast 2019-2025 / QYR9N7363資料のイメージです。• レポートコード：QYR9N7363
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥585,000 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、炎症性心疾患のグローバル市場について調査・分析したレポートで、種類別（アテローム性動脈硬化、心筋炎、心膜炎）、用途別（病院と診断センター、外来サービスセンター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・炎症性心疾患の世界市場規模
・主要企業別市場シェア
・炎症性心疾患の世界市場規模：種類別（アテローム性動脈硬化、心筋炎、心膜炎）
・炎症性心疾患の世界市場規模：用途別（病院と診断センター、外来サービスセンター）
・炎症性心疾患のアメリカ市場規模（種類別、用途別）
・炎症性心疾患のヨーロッパ市場規模（種類別、用途別）
・炎症性心疾患の中国市場規模（種類別、用途別）
・炎症性心疾患の日本市場規模（種類別、用途別）
・炎症性心疾患の東南アジア市場規模（種類別、用途別）
・炎症性心疾患のインド市場規模（種類別、用途別）
・炎症性心疾患の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・炎症性心疾患の世界市場予測（2019年-2025年）
・炎症性心疾患の地域別市場予測（2019年-2025年）
...

Inflammatory heart disease is mainly caused by various infectious agents which includes viruses, bacteria, fungi and parasites. These infectious agents came into contact with human body via various toxic materials from the environment.Changing lifestyle resulting in higher prevalence of viral and fungal infection which is a one of the major factors motivating the growth of this market. In addition, increasing healthcare expenditure by government to confront rising prevalence of cardiovascular disease. Furthermore, Continuous improvement by leading market players in Inflammatory heart disease drug and development in online pharmacy has brought new opportunity to Inflammatory heart disease market.
In 2018, the global Inflammatory Heart Disease market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Inflammatory Heart Disease status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Inflammatory Heart Disease development in United States, Europe and China.

The key players covered in this study
Abbott
Johnson & Johnson
Roche
Novartis
Pfizer
AstraZeneca
Merck
GSK
Bristol-Myers Squibb
Eli Lilly
Sanofi

Market segment by Type, the product can be split into
Atherosclerosis
Myocarditis
Pericarditis

Market segment by Application, split into
Hospitals and Diagnostic Centers
Ambulatory Services Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Inflammatory Heart Disease status, future forecast, growth opportunity, key market and key players.
To present the Inflammatory Heart Disease development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Inflammatory Heart Disease are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Inflammatory Heart Disease Market Size Growth Rate by Type (2014-2025)
1.4.2 Atherosclerosis
1.4.3 Myocarditis
1.4.4 Pericarditis
1.5 Market by Application
1.5.1 Global Inflammatory Heart Disease Market Share by Application (2014-2025)
1.5.2 Hospitals and Diagnostic Centers
1.5.3 Ambulatory Services Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Inflammatory Heart Disease Market Size
2.2 Inflammatory Heart Disease Growth Trends by Regions
2.2.1 Inflammatory Heart Disease Market Size by Regions (2014-2025)
2.2.2 Inflammatory Heart Disease Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Inflammatory Heart Disease Market Size by Manufacturers
3.1.1 Global Inflammatory Heart Disease Revenue by Manufacturers (2014-2019)
3.1.2 Global Inflammatory Heart Disease Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Inflammatory Heart Disease Market Concentration Ratio (CR5 and HHI)
3.2 Inflammatory Heart Disease Key Players Head office and Area Served
3.3 Key Players Inflammatory Heart Disease Product/Solution/Service
3.4 Date of Enter into Inflammatory Heart Disease Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Inflammatory Heart Disease Market Size by Type (2014-2019)
4.2 Global Inflammatory Heart Disease Market Size by Application (2014-2019)

5 United States
5.1 United States Inflammatory Heart Disease Market Size (2014-2019)
5.2 Inflammatory Heart Disease Key Players in United States
5.3 United States Inflammatory Heart Disease Market Size by Type
5.4 United States Inflammatory Heart Disease Market Size by Application

6 Europe
6.1 Europe Inflammatory Heart Disease Market Size (2014-2019)
6.2 Inflammatory Heart Disease Key Players in Europe
6.3 Europe Inflammatory Heart Disease Market Size by Type
6.4 Europe Inflammatory Heart Disease Market Size by Application

7 China
7.1 China Inflammatory Heart Disease Market Size (2014-2019)
7.2 Inflammatory Heart Disease Key Players in China
7.3 China Inflammatory Heart Disease Market Size by Type
7.4 China Inflammatory Heart Disease Market Size by Application

8 Japan
8.1 Japan Inflammatory Heart Disease Market Size (2014-2019)
8.2 Inflammatory Heart Disease Key Players in Japan
8.3 Japan Inflammatory Heart Disease Market Size by Type
8.4 Japan Inflammatory Heart Disease Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Inflammatory Heart Disease Market Size (2014-2019)
9.2 Inflammatory Heart Disease Key Players in Southeast Asia
9.3 Southeast Asia Inflammatory Heart Disease Market Size by Type
9.4 Southeast Asia Inflammatory Heart Disease Market Size by Application

10 India
10.1 India Inflammatory Heart Disease Market Size (2014-2019)
10.2 Inflammatory Heart Disease Key Players in India
10.3 India Inflammatory Heart Disease Market Size by Type
10.4 India Inflammatory Heart Disease Market Size by Application

11 Central & South America
11.1 Central & South America Inflammatory Heart Disease Market Size (2014-2019)
11.2 Inflammatory Heart Disease Key Players in Central & South America
11.3 Central & South America Inflammatory Heart Disease Market Size by Type
11.4 Central & South America Inflammatory Heart Disease Market Size by Application

12 International Players Profiles
12.1 Abbott
12.1.1 Abbott Company Details
12.1.2 Company Description and Business Overview
12.1.3 Inflammatory Heart Disease Introduction
12.1.4 Abbott Revenue in Inflammatory Heart Disease Business (2014-2019)
12.1.5 Abbott Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Company Details
12.2.2 Company Description and Business Overview
12.2.3 Inflammatory Heart Disease Introduction
12.2.4 Johnson & Johnson Revenue in Inflammatory Heart Disease Business (2014-2019)
12.2.5 Johnson & Johnson Recent Development
12.3 Roche
12.3.1 Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 Inflammatory Heart Disease Introduction
12.3.4 Roche Revenue in Inflammatory Heart Disease Business (2014-2019)
12.3.5 Roche Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Inflammatory Heart Disease Introduction
12.4.4 Novartis Revenue in Inflammatory Heart Disease Business (2014-2019)
12.4.5 Novartis Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Inflammatory Heart Disease Introduction
12.5.4 Pfizer Revenue in Inflammatory Heart Disease Business (2014-2019)
12.5.5 Pfizer Recent Development
12.6 AstraZeneca
12.6.1 AstraZeneca Company Details
12.6.2 Company Description and Business Overview
12.6.3 Inflammatory Heart Disease Introduction
12.6.4 AstraZeneca Revenue in Inflammatory Heart Disease Business (2014-2019)
12.6.5 AstraZeneca Recent Development
12.7 Merck
12.7.1 Merck Company Details
12.7.2 Company Description and Business Overview
12.7.3 Inflammatory Heart Disease Introduction
12.7.4 Merck Revenue in Inflammatory Heart Disease Business (2014-2019)
12.7.5 Merck Recent Development
12.8 GSK
12.8.1 GSK Company Details
12.8.2 Company Description and Business Overview
12.8.3 Inflammatory Heart Disease Introduction
12.8.4 GSK Revenue in Inflammatory Heart Disease Business (2014-2019)
12.8.5 GSK Recent Development
12.9 Bristol-Myers Squibb
12.9.1 Bristol-Myers Squibb Company Details
12.9.2 Company Description and Business Overview
12.9.3 Inflammatory Heart Disease Introduction
12.9.4 Bristol-Myers Squibb Revenue in Inflammatory Heart Disease Business (2014-2019)
12.9.5 Bristol-Myers Squibb Recent Development
12.10 Eli Lilly
12.10.1 Eli Lilly Company Details
12.10.2 Company Description and Business Overview
12.10.3 Inflammatory Heart Disease Introduction
12.10.4 Eli Lilly Revenue in Inflammatory Heart Disease Business (2014-2019)
12.10.5 Eli Lilly Recent Development
12.11 Sanofi

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Inflammatory Heart Disease Key Market Segments
Table Key Players Inflammatory Heart Disease Covered
Table Global Inflammatory Heart Disease Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Inflammatory Heart Disease Market Size Market Share by Type 2014-2025
Figure Atherosclerosis Figures
Table Key Players of Atherosclerosis
Figure Myocarditis Figures
Table Key Players of Myocarditis
Figure Pericarditis Figures
Table Key Players of Pericarditis
Table Global Inflammatory Heart Disease Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals and Diagnostic Centers Case Studies
Figure Ambulatory Services Centers Case Studies
Figure Inflammatory Heart Disease Report Years Considered
Table Global Inflammatory Heart Disease Market Size 2014-2025 (Million US$)
Figure Global Inflammatory Heart Disease Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Inflammatory Heart Disease Market Size by Regions 2014-2025 (Million US$)
Table Global Inflammatory Heart Disease Market Size by Regions 2014-2019 (Million US$)
Table Global Inflammatory Heart Disease Market Share by Regions 2014-2019
Figure Global Inflammatory Heart Disease Market Share by Regions 2014-2019
Figure Global Inflammatory Heart Disease Market Share by Regions 2019
Table Market Top Trends
Table Global Inflammatory Heart Disease Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Inflammatory Heart Disease Market Share by Manufacturers (2014-2019)
Figure Global Inflammatory Heart Disease Market Share by Manufacturers in 2018
Table Global Inflammatory Heart Disease Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Inflammatory Heart Disease Product/Solution/Service
Table Date of Enter into Inflammatory Heart Disease Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Inflammatory Heart Disease Market Size by Type (2014-2019) (Million US$)
Table Global Inflammatory Heart Disease Market Size Share by Type (2014-2019)
Figure Global Inflammatory Heart Disease Market Size Market Share by Type (2014-2019)
Table Global Inflammatory Heart Disease Market Size by Application (2014-2019) (Million US$)
Table Global Inflammatory Heart Disease Market Size Share by Application (2014-2019)
Figure Global Inflammatory Heart Disease Market Size Market Share by Application (2014-2019)
Figure Global Inflammatory Heart Disease Revenue Market Share by Application in 2018
Figure United States Inflammatory Heart Disease Market Size 2014-2019 (Million US$)
Table United States Key Players Inflammatory Heart Disease Revenue (2018-2019) (Million US$)
Table United States Key Players Inflammatory Heart Disease Market Share (2018-2019)
Table United States Inflammatory Heart Disease Market Size by Type (2014-2019) (Million US$)
Table United States Inflammatory Heart Disease Market Share by Type (2014-2019)
Table United States Inflammatory Heart Disease Market Size by Application (2014-2019) (Million US$)
Table United States Inflammatory Heart Disease Market Share by Application (2014-2019)
Figure Europe Inflammatory Heart Disease Market Size 2014-2019 (Million US$)
Table Europe Key Players Inflammatory Heart Disease Revenue (2018-2019) (Million US$)
Table Europe Key Players Inflammatory Heart Disease Market Share (2018-2019)
Table Europe Inflammatory Heart Disease Market Size by Type (2014-2019) (Million US$)
Table Europe Inflammatory Heart Disease Market Share by Type (2014-2019)
Table Europe Inflammatory Heart Disease Market Size by Application (2014-2019) (Million US$)
Table Europe Inflammatory Heart Disease Market Share by Application (2014-2019)
Figure China Inflammatory Heart Disease Market Size 2014-2019 (Million US$)
Table China Key Players Inflammatory Heart Disease Revenue (2018-2019) (Million US$)
Table China Key Players Inflammatory Heart Disease Market Share (2018-2019)
Table China Inflammatory Heart Disease Market Size by Type (2014-20189) (Million US$)
Table China Inflammatory Heart Disease Market Share by Type (2014-2019)
Table China Inflammatory Heart Disease Market Size by Application (2014-2019) (Million US$)
Table China Inflammatory Heart Disease Market Share by Application (2014-2019)
Figure Japan Inflammatory Heart Disease Market Size 2014-2019 (Million US$)
Table Japan Key Players Inflammatory Heart Disease Revenue (2018-2019) (Million US$)
Table Japan Key Players Inflammatory Heart Disease Market Share (2018-2019)
Table Japan Inflammatory Heart Disease Market Size by Type (2014-2019) (Million US$)
Table Japan Inflammatory Heart Disease Market Share by Type (2014-2019)
Table Japan Inflammatory Heart Disease Market Size by Application (2014-2019) (Million US$)
Table Japan Inflammatory Heart Disease Market Share by Application (2014-2019)
Figure Southeast Asia Inflammatory Heart Disease Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Inflammatory Heart Disease Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Inflammatory Heart Disease Market Share (2018-2019)
Table Southeast Asia Inflammatory Heart Disease Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Inflammatory Heart Disease Market Share by Type (2014-2019)
Table Southeast Asia Inflammatory Heart Disease Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Inflammatory Heart Disease Market Share by Application (2014-2019)
Figure India Inflammatory Heart Disease Market Size 2014-2019 (Million US$)
Table India Key Players Inflammatory Heart Disease Revenue (2018-2019) (Million US$)
Table India Key Players Inflammatory Heart Disease Market Share (2018-2019)
Table India Inflammatory Heart Disease Market Size by Type (2014-2019) (Million US$)
Table India Inflammatory Heart Disease Market Share by Type (2014-2019)
Table India Inflammatory Heart Disease Market Size by Application (2014-2019) (Million US$)
Table India Inflammatory Heart Disease Market Share by Application (2014-2019)
Figure Central & South America Inflammatory Heart Disease Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Inflammatory Heart Disease Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Inflammatory Heart Disease Market Share (2018-2019)
Table Central & South America Inflammatory Heart Disease Market Size by Type (2014-2019) (Million US$)
Table Central & South America Inflammatory Heart Disease Market Share by Type (2014-2019)
Table Central & South America Inflammatory Heart Disease Market Size by Application (2014-2019) (Million US$)
Table Central & South America Inflammatory Heart Disease Market Share by Application (2014-2019)
Table Abbott Company Details
Table Abbott Revenue in Inflammatory Heart Disease Business (2014-2019) (Million US$)
Figure Abbott Revenue Growth Rate in Inflammatory Heart Disease Business (2014-2019)
Table Abbott Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Inflammatory Heart Disease Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Inflammatory Heart Disease Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Roche Company Details
Table Roche Revenue in Inflammatory Heart Disease Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Inflammatory Heart Disease Business (2014-2019)
Table Roche Recent Development
Table Novartis Company Details
Table Novartis Revenue in Inflammatory Heart Disease Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Inflammatory Heart Disease Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Inflammatory Heart Disease Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Inflammatory Heart Disease Business (2014-2019)
Table Pfizer Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Inflammatory Heart Disease Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Inflammatory Heart Disease Business (2014-2019)
Table AstraZeneca Recent Development
Table Merck Company Details
Table Merck Revenue in Inflammatory Heart Disease Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Inflammatory Heart Disease Business (2014-2019)
Table Merck Recent Development
Table GSK Company Details
Table GSK Revenue in Inflammatory Heart Disease Business (2014-2019)(Million US$)
Figure GSK Revenue Growth Rate in Inflammatory Heart Disease Business (2014-2019)
Table GSK Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Inflammatory Heart Disease Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Inflammatory Heart Disease Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Inflammatory Heart Disease Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Inflammatory Heart Disease Business (2014-2019)
Table Eli Lilly Recent Development
Table Sanofi Company Details
Table Global Inflammatory Heart Disease Market Size by Regions (Million US$) 2019-2025
Figure Global Inflammatory Heart Disease Market Size Share by Regions (2019-2025)
Figure Global Inflammatory Heart Disease Market Size Share by Regions in 2025
Figure United States Inflammatory Heart Disease Market Size Forecast (2019-2025)(Million USD)
Figure Europe Inflammatory Heart Disease Market Size Forecast (2019-2025)(Million USD)
Figure China Inflammatory Heart Disease Market Size Forecast (2019-2025)(Million USD)
Figure Japan Inflammatory Heart Disease Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Inflammatory Heart Disease Market Size Forecast (2019-2025)(Million USD)
Figure India Inflammatory Heart Disease Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Inflammatory Heart Disease Market Size Forecast (2019-2025)(Million USD)
Table Global Inflammatory Heart Disease Market Size by Product (2019-2025) (Million US$)
Figure Global Inflammatory Heart Disease Market Size by Product (2019-2025)
Figure Global Inflammatory Heart Disease Market Size by Product in 2025
Table Global Inflammatory Heart Disease Market Size by Application (2019-2025) (Million US$)
Figure Global Inflammatory Heart Disease Market Size by Application (2019-2025)
Figure Global Inflammatory Heart Disease Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の炎症性腸疾患（IBD）治療学市場：市場規模・現状・予測
    Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7361 2019年6月14日 96Pages
    当資料は、炎症性腸疾患（IBD）治療学のグローバル市場について調査・分析したレポートで、種類別（抗炎症バイオ医薬品、非ステロイド系抗炎症薬（NSAID）、コルチコステロイド）、用途別（病院、研究）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企...
  • 世界の先天性心疾患市場：市場規模・現状・予測
    Global Congenital Heart Disease Market Size, Status and Forecast 2019-2025
    QYR9N7012 2019年6月14日 103Pages
    当資料は、先天性心疾患のグローバル市場について調査・分析したレポートで、種類別（薬、植込み型心臓デバイス、カテーテル手順、開心術、心臓移植）、用途別（病院と診療所、診断センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれ...
  • 世界の炎症性腸疾患（IBD）の治療市場：市場規模・現状・予測
    Global Inflammatory Bowel Disease (IBD) Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7362 2019年6月14日 98Pages
    当資料は、炎症性腸疾患（IBD）の治療のグローバル市場について調査・分析したレポートで、種類別（TNF阻害剤、アミノサリチル酸、免疫調節剤、コルチコステロイド）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予...
  • 世界のまれな炎症性疾患の治療市場：市場規模・現状・予測
    Global Rare Inflammatory Disease Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7937 2019年6月14日 90Pages
    当資料は、まれな炎症性疾患の治療のグローバル市場について調査・分析したレポートで、種類別（注射剤、経口、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界のリウマチ性心疾患市場：市場規模・現状・予測
    Global Rheumatic Heart Disease Market Size, Status and Forecast 2019-2025
    QYR9N7970 2019年6月14日 106Pages
    当資料は、リウマチ性心疾患のグローバル市場について調査・分析したレポートで、種類別（弁、心筋炎、心膜炎）、用途別（病院、診断センター、研究センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界の炎症性皮膚疾患の治療市場：市場規模・現状・予測
    Global Inflammatory Skin Diseases Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7365 2019年6月14日 97Pages
    当資料は、炎症性皮膚疾患の治療のグローバル市場について調査・分析したレポートで、種類別（レチノイド、コルチコステロイド、カルシニューリン阻害剤、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連...
  • 世界の炎症性皮膚疾患薬市場：市場規模・現状・予測
    Global Inflammatory Skin Diseases Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7364 2019年6月14日 93Pages
    当資料は、炎症性皮膚疾患薬のグローバル市場について調査・分析したレポートで、種類別（レチノイド、コルチコステロイド、カルシニューリン阻害剤、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業...
  • 世界の非ステロイド系抗炎症薬（NSAID）市場：市場規模・現状・予測
    Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, Status and Forecast 2019-2025
    QYR9N7690 2019年6月14日 97Pages
    当資料は、非ステロイド系抗炎症薬（NSAID）のグローバル市場について調査・分析したレポートで、種類別（パラセタモール、イブプロフェン、アスピリン、ナプロキセン、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規...
  • 世界の構造心臓イメージング（SHI）市場：市場規模・現状・予測
    Global Structural Heart Imaging (SHI) Market Size, Status and Forecast 2019-2025
    QYR9N8086 2019年6月14日 97Pages
    当資料は、構造心臓イメージング（SHI）のグローバル市場について調査・分析したレポートで、種類別（成人、子供）、用途別（カーディオコムソリューションズ、サークル心血管イメージング株式会社、ハートサイエンス、コーニンクレッカフィリップスN.V.、パイメディカルイメージング、その他）、主要地域別（アメリ...
  • 世界のフォンヴィレブランド病治療市場：市場規模・現状・予測
    Global Von Willebrand Disease Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8188 2019年6月14日 93Pages
    当資料は、フォンヴィレブランド病治療のグローバル市場について調査・分析したレポートで、種類別（ヴェイヴォンディ、フミン酸-P、英数字、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...